Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine- dimethylaminohydrolase activity

Endocrinology

Volumn 149, Issue 6, 2008, Pages 3148-3157

  Ellger, Björn ^a,b   Richir, Milan C ^c   Van Leeuwen, Paul A M ^c   Debaveye, Yves ^a   Langouche, Lies ^a   Vanhorebeek, Ilse ^a   Teerlink, Tom ^c   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CREATININE; DIMETHYLARGININASE; INSULIN; N(G),N(G) DIMETHYLARGININE; UREA;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CRITICAL ILLNESS; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMIDOHYDROLASES; ANIMALS; ARGININE; BLOOD GLUCOSE; BODY WEIGHT; CREATININE; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; HUMANS; INSULIN; RABBITS;

EID: 44249089727     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1558     Document Type: Article

References (50)

1. Van den Berghe G 2002 Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol 23:370-391
2. Wolfe RR, Martini WZ 2000 Changes in intermediary metabolism in severe surgical illness. World J Surg 24:639-647
3. Nasraway Jr SA 2006 Hyperglycemia during critical illness. JPEN J Parenter Enteral Nutr 30:254-258
4. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
5. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R 2006 Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461
6. Krinsley JS 2004 Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79:992-1000
7. Van den Berghe G 2004 How does blood glucose control with insulin save lives in intensive care? J Clin Invest 114:1187-1195
8. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G 2005 Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115:2277-2286
9. Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters PJ, Van den Berghe G 2005 Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 33:504-510
10. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G 2006 Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55:1096-1105
11. Vallance P, Leone A, Calver A, Collier J, Moncada S 1992 Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575
12. Wheatcroft SB, Williams IL, Shah AM, Kearney MT 2003 Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20:255-268
13. Li H, Wallerath T, Forstermann U 2002 Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 7:132-147
14. Hallemeesch MM, Janssen BJ, de Jonge WJ, Soeters PB, Lamers WH, Deutz NE 2003 NO production by cNOS and iNOS reflects blood pressure changes in LPS-challenged mice. Am J Physiol Endocrinol Metab 285:E871-E875
15. Rawlingson A 2003 Nitric oxide, inflammation and acute burn injury. Burns 29:631-640
16. Kobayashi T, Kamata K 2001 Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats. Atherosclerosis 155:313-320
17. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF 1997 High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25-28
18. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R 2004 Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30
19. Nijveldt RJ, Teerlink T, Van Der Hoven B, Siroen MP, Kuik DJ, Rauwerda JA, van Leeuwen PA 2003 Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 22:23-30
20. Siroen MP, Teerlink T, Nijveldt RJ, Prins HA, Richir MC, van Leeuwen PA 2006 The clinical significance of asymmetric dimethylarginine. Annu Rev Nutr 26:203-228
21. Vallance P, Leone A, Calver A, Collier J, Moncada S 1992 Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20(Suppl 12):S60-S62
22. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP 1998 Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842-1847
23. Closs EI, Basha FZ, Habermeier A, Forstermann U 1997 Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1:65-73
24. Marliss EB, Chevalier S, Gougeon R, Morais JA, Lamarche M, Adegoke OA, Wu G 2006 Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover. Diabetologia 49:351-359
25. Tran CT, Leiper JM, Vallance P 2003 The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4:33-40
26. Teerlink T 2005 ADMA metabolism and clearance. Vasc Med 10(Suppl 1):S73-S81
27. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P 2003 Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23:1455-1459
28. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D 2006 Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-a meta-analysis. Nephrol Dial Transplant 21:2446-2451
29. Nijveldt RJ, Teerlink T, Siroen MP, van Lambalgen AA, Rauwerda JA, van Leeuwen PA 2003 The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 22:17-22
30. Nijveldt RJ, Teerlink T, van Guldener C, Prins HA, van Lambalgen AA, Stehouwer CD, Rauwerda JA, van Leeuwen PA 2003 Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant 18:2542-2550
31. Ellger B, Richir MC, Langouche L, Debaveye Y, Vanhorebeek I, van Leeuwen PA, Van den Berghe G 2006 Endothelial dysfunction in critical illness: glycemic control or glycemia independent actions of insulin? Intensive Care Med 32:S237 (Abstract)
32. Weekers F, Giulietti AP, Michalaki M, Coopmans W, Van Herck E, Mathieu C, Van den Berghe G 2003 Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144:5329-5338
33. Partridge GG, Lobley GE, Fordyce RA 1986 Energy and nitrogen metabolism of rabbits during pregnancy, lactation, and concurrent pregnancy and lactation. Br J Nutr 56:199-207
34. Nyomba BL, Bouillon R, De Moor P 1984 Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 115:191-197
35. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
36. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA 2002 Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303:131-137
37. de Jong S, Teerlink T 2006 Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal Biochem 353:287-289
38. Teerlink T, van Leeuwen PA, Houdijk A 1994 Plasma amino acids determined by liquid chromatography within 17 minutes. Clin Chem 40:245-249
39. Siroen MP, Teerlink T, Bolte AC, van Elburg RM, Richir MC, Nijveldt RJ, Van Der Hoven B, van Leeuwen PA 2006 No compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia. Gynecol Obstet Invest 62:7-13
40. Kinney JM, Elwyn DH 1985 Protein metabolism in the traumatized patient. Acta Chir Scand Suppl 522:45-56
41. Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS 2002 Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287:1420-1426
42. Sorrenti V, Mazza F, Campisi A, Vanella L, Li Volti G, Di Giacomo C 2006 High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells. Curr Neurovasc Res 3:49-54
43. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T 1999 Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99:1141-1146
44. Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP 2002 Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106:987-992
45. Tsikas D, Boger RH, Sandmann J, Bode-Boger SM, Frolich JC 2000 Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett 478:1-3
46. Garlick PJ, Waterlow JC, Swick RW 1976 Measurement of protein turnover in rat liver. Analysis of the complex curve for decay of label in a mixture of proteins. Biochem J 156:657-663
47. Mesotten D, Delhanty PJ, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van den Berghe G 2002 Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 87:5516-5523
48. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H, Whitley GS, Vallance P 1996 Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119:1533-1540
49. Lu CW, Xiong Y, He P 2007 Dimethylarginine dimethylaminohydrolase- 2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein. Nitric Oxide 16:94-103
50. Liu J, Hatzoglou M 1998 Control of expression of the gene for the arginine transporter Cat-1 in rat liver cells by glucocorticoids and insulin. Amino Acids 15:321-337